• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析液钠浓度对透析间期钾增加的影响。

Effect of dialysate sodium concentration on interdialytic increase of potassium.

作者信息

Nicola Luca DE, Bellizzi Vincenzo, Minutolo Roberto, Cioffi Mario, Giannattasio Paolo, Terracciano Vincenzo, Iodice Carmela, Uccello Francesco, Memoli Bruno, Iorio Biagio Raffaele DI, Conte Giuseppe

机构信息

Chair of Nephrology, School of Medicine, Second University of Naples, Italy.

Chair of Nephrology, School of Medicine, Lauria Hospital, Lauria, Italy.

出版信息

J Am Soc Nephrol. 2000 Dec;11(12):2337-2343. doi: 10.1681/ASN.V11122337.

DOI:10.1681/ASN.V11122337
PMID:11095656
Abstract

To evaluate the role of plasma tonicity in the postdialysis increment of plasma potassium (p[K(+)]), the outcome of two hemodiafiltration treatments that differed only in the Na(+) level in dialysate (Na(D))-143 mmol/L (high dialysate sodium concentration [H-Na(D)]) and 138 mmol/L (low dialysate sodium concentration [L-Na(D)])-were compared in the same group of uremic patients from the end of treatment (T0) to the subsequent 30 to 120 min and up to 68 h. Kt/V and intradialytic K(+) removal were comparable. At T0, plasma [Na(+)] was 145+/-1 and 137+/-1 mmol/L after H-Na(D) and L-Na(D), respectively (P<0.001). The difference in plasma tonicity persisted from T0 to T68 h. At T120, p[K(+)] was increased from the T0 value of 3.7+/-0.2 to 4.7+/-0.2 mmol/L (P<0.05) after H-Na(D), whereas it was unchanged after L-Na(D). The change of p[K(+)] was still different after 68 h (+76+/-10% and +50+/-7% in H-Na(D) and L-Na(D), respectively; P<0.05). Of note, in the first 2 h after the end of treatment, bioimpedance analysis revealed only in H-Na(D) a significant 11+/-3% decrement of phase angle that is compatible with a decrease of intracellular fluid volume at the expense of the extracellular volume. Similarly, within the same time frame, in H-Na(D), a significant reduction of mean corpuscular volume of red cells, associated with a 2 +/-1% decrease of the intracellular [K(+)], was observed. In contrast, mean corpuscular volume of red cells did not change and erythrocyte [K(+)] increased by 6+/-1% after L-Na(D) (P<0.005 versus H-Na(D)). Thus, hypertonicity significantly contributes to the increase of p[K(+)] throughout the whole interdialytic period by determining intracellular fluid volume/extracellular volume redistribution of water and K(+).

摘要

为评估血浆渗透压在透析后血浆钾(p[K⁺])升高过程中的作用,在同一组尿毒症患者中比较了两种血液透析滤过治疗的结果,这两种治疗仅透析液中钠(Na(D))水平不同——143 mmol/L(高透析液钠浓度 [H-Na(D)])和138 mmol/L(低透析液钠浓度 [L-Na(D)])——从治疗结束时(T0)至随后的30至120分钟以及长达68小时。Kt/V和透析期间钾(K⁺)清除率相当。在T0时,H-Na(D)和L-Na(D)后血浆[Na⁺]分别为145±1和137±1 mmol/L(P<0.001)。血浆渗透压的差异从T0持续到T68小时。在T120时,H-Na(D)后p[K⁺]从T0时的3.7±0.2 mmol/L升高至4.7±0.2 mmol/L(P<0.05),而L-Na(D)后则无变化。68小时后p[K⁺]的变化仍有差异(H-Na(D)和L-Na(D)分别为+76±10%和+50±7%;P<0.05)。值得注意的是,在治疗结束后的最初2小时内,生物电阻抗分析显示仅在H-Na(D)中有相角显著下降11±3%,这与细胞内液体积以细胞外液体积为代价减少相一致。同样,在同一时间范围内,在H-Na(D)中,观察到红细胞平均体积显著减小,同时细胞内[K⁺]降低2±1%。相反,L-Na(D)后红细胞平均体积未改变,红细胞[K⁺]增加6±1%(与H-Na(D)相比,P<0.005)。因此,高渗状态通过决定水和K⁺的细胞内液体积/细胞外液体积再分布,在整个透析间期显著促成p[K⁺]升高。

相似文献

1
Effect of dialysate sodium concentration on interdialytic increase of potassium.透析液钠浓度对透析间期钾增加的影响。
J Am Soc Nephrol. 2000 Dec;11(12):2337-2343. doi: 10.1681/ASN.V11122337.
2
Automated individualization of dialysate sodium concentration reduces intradialytic plasma sodium changes in hemodialysis.自动化调整透析液钠浓度可减少血液透析过程中的血浆钠变化。
Artif Organs. 2019 Oct;43(10):1002-1013. doi: 10.1111/aor.13463. Epub 2019 Apr 29.
3
Effects of different dialysate calcium concentrations on intradialysis hemodynamic stability.不同透析液钙浓度对透析中血液动力学稳定性的影响。
J Nephrol. 2012 Jul-Aug;25(4):506-14. doi: 10.5301/jn.5000023.
4
Hydroelectrolytic equilibrium change in dialysis.透析中的水电解质平衡变化
J Nephrol. 2001 Nov-Dec;14 Suppl 4:S7-11.
5
Sodium flux during hemodialysis and hemodiafiltration treatment of acute kidney injury: Effects of dialysate and infusate sodium concentration at 140 and 145 mmol/L.急性肾损伤血液透析和血液透析滤过治疗中的钠通量:140 和 145 mmol/L 时透析液和输液中钠浓度的影响。
Artif Organs. 2023 Jun;47(6):999-1006. doi: 10.1111/aor.14487. Epub 2023 Jan 9.
6
Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.降低透析后血浆钠(电导率)以增加容量扩张血液透析患者的钠清除:使用生物反馈软件系统的初步研究。
Am J Kidney Dis. 2010 Jul;56(1):69-76. doi: 10.1053/j.ajkd.2009.12.037. Epub 2010 Mar 19.
7
Ranking of factors determining potassium mass balance in bicarbonate haemodialysis.碳酸氢盐血液透析中钾质量平衡的决定因素的排序。
Nephrol Dial Transplant. 2015 Mar;30(3):505-13. doi: 10.1093/ndt/gfu376. Epub 2014 Dec 13.
8
Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain.透析液钠浓度在设施层面的降低与血压及透析间期体重增加的关联。
Nephrol Dial Transplant. 2007 Sep;22(9):2630-9. doi: 10.1093/ndt/gfm220. Epub 2007 May 17.
9
Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis.在血液透析过程中,迅速改变血浆钠离子浓度会改变血压。
Nephrol Dial Transplant. 2013 Aug;28(8):2181-6. doi: 10.1093/ndt/gft081. Epub 2013 Jun 5.
10
Erythrocyte sodium transport in dialyzed uremic patients.透析尿毒症患者的红细胞钠转运
Korean J Intern Med. 1989 Jan;4(1):9-17. doi: 10.3904/kjim.1989.4.1.9.

引用本文的文献

1
Low dialysate sodium levels for chronic haemodialysis.慢性血液透析中低透析液钠水平。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD011204. doi: 10.1002/14651858.CD011204.pub3.
2
Effect of banana intake on serum potassium level in patients undergoing maintenance hemodialysis: A randomized controlled trial.香蕉摄入对维持性血液透析患者血清钾水平的影响:一项随机对照试验。
Int J Nurs Sci. 2024 Mar 14;11(2):197-204. doi: 10.1016/j.ijnss.2024.03.016. eCollection 2024 Apr.
3
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers.
慢性肾脏病中的慢性高钾血症:旧有担忧,新有答案。
Int J Mol Sci. 2022 Jun 7;23(12):6378. doi: 10.3390/ijms23126378.
4
Altered dietary salt intake for people with chronic kidney disease.改变慢性肾脏病患者的饮食盐摄入量。
Cochrane Database Syst Rev. 2021 Jun 24;6(6):CD010070. doi: 10.1002/14651858.CD010070.pub3.
5
Personalizing potassium management in patients on haemodialysis.个性化血液透析患者的钾管理
Nephrol Dial Transplant. 2021 Jan 1;36(1):13-18. doi: 10.1093/ndt/gfaa213.
6
Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology.肾脏病患者高钾血症的管理:意大利肾脏病学会认可的立场文件。
J Nephrol. 2019 Aug;32(4):499-516. doi: 10.1007/s40620-019-00617-y. Epub 2019 May 22.
7
Low dialysate sodium levels for chronic haemodialysis.慢性血液透析的低透析液钠水平
Cochrane Database Syst Rev. 2019 Jan 16;1(1):CD011204. doi: 10.1002/14651858.CD011204.pub2.
8
Hypertension in patients on dialysis: diagnosis, mechanisms, and management.透析患者的高血压:诊断、机制与管理
J Bras Nefrol. 2019 Jul-Sep;41(3):400-411. doi: 10.1590/2175-8239-jbn-2018-0155. Epub 2018 Nov 8.
9
A neglected issue in dialysis practice: haemodialysate.透析实践中一个被忽视的问题:血液透析液。
Clin Kidney J. 2015 Aug;8(4):393-9. doi: 10.1093/ckj/sfv038. Epub 2015 May 28.
10
Outcomes after the long interdialytic break: implications for the dialytic prescription.长时间透析间期后的结果:对透析处方的影响
Semin Dial. 2012 Jan-Feb;25(1):1-8. doi: 10.1111/j.1525-139X.2011.01015.x.